FindTrial
Sign In

Comparison of long-term oncologic and perioperative outcomes of minimally invasive and open pancreatoduodenectomy for resectable and borderline resectable pancreatic ductal adenocarcinoma: exploring type 0 resection as a potential indication for MIPD

Comparison of long-term oncologic and perioperative outcomes of minimally invasive and open pancreatoduodenectomy for resectable and borderline resectable pancreatic ductal adenocarcinoma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0009911
Enrollment
550
Registered
2024-11-08
Start date
2024-11-05
Completion date
Unknown
Last updated
2024-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Yonsei University Health System, Severance Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All patients who underwent minimally invasive pancreatoduodenectomy and open pancreatoduodenectomy for the treatment of pancreatic cancer.

Exclusion criteria

Exclusion criteria: Stage IV pancreatic cancer patients for whom curative resection is not possible (palliative surgery).

Design outcomes

Primary

MeasureTime frame
overall survival—

Secondary

MeasureTime frame
disease free survival—

Countries

Korea, Republic of

Contacts

Public ContactMunseok Choi

Yonsei University Yongin Severance Hospital

cms2598@yuhs.ac+82-2-2228-2135

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026